Significant T cell-surface decoration with EGFR-LiTE persisted for 4 days in vitro, indicating that, despite the transient nature of mRNA, engineered T lymphocytes remain armored to attack cancer cells for several days. The gene discussed is EGFR; the disease is cancer.